281 related articles for article (PubMed ID: 18832576)
1. Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset.
Kesari A; Fukuda M; Knoblach S; Bashir R; Nader GA; Rao D; Nagaraju K; Hoffman EP
Am J Pathol; 2008 Nov; 173(5):1476-87. PubMed ID: 18832576
[TBL] [Abstract][Full Text] [Related]
2. Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B.
Nagaraju K; Rawat R; Veszelovszky E; Thapliyal R; Kesari A; Sparks S; Raben N; Plotz P; Hoffman EP
Am J Pathol; 2008 Mar; 172(3):774-85. PubMed ID: 18276788
[TBL] [Abstract][Full Text] [Related]
3. Dysferlinopathy: a clinical and histopathological study of 28 patients from India.
Nalini A; Gayathri N
Neurol India; 2008; 56(3):379-85; discussion 386-7. PubMed ID: 18974568
[TBL] [Abstract][Full Text] [Related]
4. New aspects on patients affected by dysferlin deficient muscular dystrophy.
Klinge L; Aboumousa A; Eagle M; Hudson J; Sarkozy A; Vita G; Charlton R; Roberts M; Straub V; Barresi R; Lochmüller H; Bushby K
J Neurol Neurosurg Psychiatry; 2010 Sep; 81(9):946-53. PubMed ID: 19528035
[TBL] [Abstract][Full Text] [Related]
5. Lipid accumulation in dysferlin-deficient muscles.
Grounds MD; Terrill JR; Radley-Crabb HG; Robertson T; Papadimitriou J; Spuler S; Shavlakadze T
Am J Pathol; 2014 Jun; 184(6):1668-76. PubMed ID: 24685690
[TBL] [Abstract][Full Text] [Related]
6. DYSF mutation analysis in a group of Chinese patients with dysferlinopathy.
Zhao Z; Hu J; Sakiyama Y; Okamoto Y; Higuchi I; Li N; Shen H; Takashima H
Clin Neurol Neurosurg; 2013 Aug; 115(8):1234-7. PubMed ID: 23254335
[TBL] [Abstract][Full Text] [Related]
7. Dysferlin protein analysis in limb-girdle muscular dystrophies.
Vainzof M; Anderson LV; McNally EM; Davis DB; Faulkner G; Valle G; Moreira ES; Pavanello RC; Passos-Bueno MR; Zatz M
J Mol Neurosci; 2001 Aug; 17(1):71-80. PubMed ID: 11665864
[TBL] [Abstract][Full Text] [Related]
8. Painful enlargement of the calf muscles in limb girdle muscular dystrophy type 2B (LGMD2B) with a novel compound heterozygous mutation in DYSF.
Diers A; Carl M; Stoltenburg-Didinger G; Vorgerd M; Spuler S
Neuromuscul Disord; 2007 Feb; 17(2):157-62. PubMed ID: 17129727
[TBL] [Abstract][Full Text] [Related]
9. Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle.
Rawat R; Cohen TV; Ampong B; Francia D; Henriques-Pons A; Hoffman EP; Nagaraju K
Am J Pathol; 2010 Jun; 176(6):2891-900. PubMed ID: 20413686
[TBL] [Abstract][Full Text] [Related]
10. Redefining dysferlinopathy phenotypes based on clinical findings and muscle imaging studies.
Paradas C; Llauger J; Diaz-Manera J; Rojas-García R; De Luna N; Iturriaga C; Márquez C; Usón M; Hankiewicz K; Gallardo E; Illa I
Neurology; 2010 Jul; 75(4):316-23. PubMed ID: 20574037
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes.
Nguyen K; Bassez G; Krahn M; Bernard R; Laforêt P; Labelle V; Urtizberea JA; Figarella-Branger D; Romero N; Attarian S; Leturcq F; Pouget J; Lévy N; Eymard B
Arch Neurol; 2007 Aug; 64(8):1176-82. PubMed ID: 17698709
[TBL] [Abstract][Full Text] [Related]
12. Case report of an adolescent girl with limb-girdle muscular dystrophy type 2B - the usefulness of muscle protein immunostaining in the diagnosis of dysferlinopathies.
Szymanska S; Rokicki D; Karkucinska-Wieckowska A; Szymanska-Debinska T; Ciara E; Ploski R; Grajkowska W; Pronicki M
Folia Neuropathol; 2014; 52(4):452-6. PubMed ID: 25574751
[TBL] [Abstract][Full Text] [Related]
13. Identical mutation in patients with limb girdle muscular dystrophy type 2B or Miyoshi myopathy suggests a role for modifier gene(s).
Weiler T; Bashir R; Anderson LV; Davison K; Moss JA; Britton S; Nylen E; Keers S; Vafiadaki E; Greenberg CR; Bushby CR; Wrogemann K
Hum Mol Genet; 1999 May; 8(5):871-7. PubMed ID: 10196377
[TBL] [Abstract][Full Text] [Related]
14. [Amyloidosis in muscular dystrophy].
Carl M; Röcken C; Spuler S
Pathologe; 2009 May; 30(3):235-9. PubMed ID: 19326120
[TBL] [Abstract][Full Text] [Related]
15. Dysfunction of dysferlin-deficient hearts.
Wenzel K; Geier C; Qadri F; Hubner N; Schulz H; Erdmann B; Gross V; Bauer D; Dechend R; Dietz R; Osterziel KJ; Spuler S; Ozcelik C
J Mol Med (Berl); 2007 Nov; 85(11):1203-14. PubMed ID: 17828519
[TBL] [Abstract][Full Text] [Related]
16. Dysferlin interacts with calsequestrin-1, myomesin-2 and dynein in human skeletal muscle.
Flix B; de la Torre C; Castillo J; Casal C; Illa I; Gallardo E
Int J Biochem Cell Biol; 2013 Aug; 45(8):1927-38. PubMed ID: 23792176
[TBL] [Abstract][Full Text] [Related]
17. Efficient recovery of dysferlin deficiency by dual adeno-associated vector-mediated gene transfer.
Lostal W; Bartoli M; Bourg N; Roudaut C; Bentaïb A; Miyake K; Guerchet N; Fougerousse F; McNeil P; Richard I
Hum Mol Genet; 2010 May; 19(10):1897-907. PubMed ID: 20154340
[TBL] [Abstract][Full Text] [Related]
18. [Mutational and clinical features of Japanese patients with dysferlinopathy (Miyoshi myopathy and limb girdle muscular dystrophy type 2B)].
Aoki M; Takahashi T
Rinsho Shinkeigaku; 2005 Nov; 45(11):938-42. PubMed ID: 16447768
[TBL] [Abstract][Full Text] [Related]
19. Dysferlin deficiency and the development of cardiomyopathy in a mouse model of limb-girdle muscular dystrophy 2B.
Chase TH; Cox GA; Burzenski L; Foreman O; Shultz LD
Am J Pathol; 2009 Dec; 175(6):2299-308. PubMed ID: 19875504
[TBL] [Abstract][Full Text] [Related]
20. Clinical features and a mutation with late onset of limb girdle muscular dystrophy 2B.
Takahashi T; Aoki M; Suzuki N; Tateyama M; Yaginuma C; Sato H; Hayasaka M; Sugawara H; Ito M; Abe-Kondo E; Shimakura N; Ibi T; Kuru S; Wakayama T; Sobue G; Fujii N; Saito T; Matsumura T; Funakawa I; Mukai E; Kawanami T; Morita M; Yamazaki M; Hasegawa T; Shimizu J; Tsuji S; Kuzuhara S; Tanaka H; Yoshioka M; Konno H; Onodera H; Itoyama Y
J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):433-40. PubMed ID: 23243261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
